secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aclaris Therapeutics, Inc. (ACRS)
CIK:        0001557746
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001558370-23-000121
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aclaris presents at J.P. Morgan Healthcare Conference on Jan 11; no material financial updates
--------------------------------------------------------------------------------

- Management presents company overview and slide deck at 41st Annual J.P. Morgan Healthcare Conference on Jan 11, 2023.
- Presentation focuses on Aclaris' kinome innovation platform; no specific product or pipeline data disclosed.
- No financial guidance, clinical trial results, or material corporate developments included in the filing.
- Filing is a procedural disclosure under Regulation FD; exhibit contains only cover slide with no substantive new information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557746/000155837023000121/0001558370-23-000121-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557746/000155837023000121/acrs-20230109x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-000121

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer